JACOBS LEVY EQUITY MANAGEMENT, INC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,095,384
-71.0%
144,611
-76.5%
0.02%
-72.4%
Q1 2023$14,115,823
+7.2%
614,533
+31.1%
0.09%
-2.2%
Q4 2022$13,162,388
-4.4%
468,746
-3.7%
0.09%
-18.3%
Q3 2022$13,765,000
+56.4%
486,726
+22.6%
0.11%
+60.3%
Q2 2022$8,802,000
-35.1%
397,015
-14.8%
0.07%
-25.3%
Q1 2022$13,561,000
+33.9%
465,852
+51.2%
0.09%
+33.8%
Q4 2021$10,125,000
-27.5%
308,041
+1.8%
0.07%
-27.7%
Q3 2021$13,963,000
+16.2%
302,547
+38.8%
0.09%
+16.0%
Q2 2021$12,015,000
+14.5%
218,022
+7.3%
0.08%0.0%
Q1 2021$10,497,000
+107.8%
203,276
+74.4%
0.08%
+84.1%
Q4 2020$5,052,000
+5.9%
116,586
-14.5%
0.04%
-10.2%
Q3 2020$4,770,000
+101.8%
136,287
+208.4%
0.05%
+88.5%
Q2 2020$2,364,000
+166.8%
44,197
+185.1%
0.03%
+62.5%
Q4 2017$886,000
-78.6%
15,500
-80.3%
0.02%
-78.4%
Q3 2016$4,148,000
+198.4%
78,537
+136.6%
0.07%
+155.2%
Q2 2016$1,390,00033,1900.03%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,661,605$61,137,0671.46%
Bellevue Group AG 4,013,500$92,190,0951.34%
Eagle Health Investments LP 267,630$6,147,4611.20%
ARMISTICE CAPITAL, LLC 3,460,000$79,476,2001.14%
Integral Health Asset Management, LLC 213,000$4,892,6100.99%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$10,428,3800.44%
ArrowMark Colorado Holdings LLC 1,557,705$35,780,4840.41%
FARALLON CAPITAL MANAGEMENT LLC 2,092,829$48,072,2820.27%
Virtus ETF Advisers LLC 9,932$228,1380.13%
JACOBS LEVY EQUITY MANAGEMENT, INC 614,533$14,115,8230.09%
View complete list of AGIOS PHARMACEUTICALS INC shareholders